InvestorsHub Logo
Followers 10
Posts 485
Boards Moderated 0
Alias Born 12/02/2016

Re: None

Wednesday, 04/19/2017 9:28:42 AM

Wednesday, April 19, 2017 9:28:42 AM

Post# of 158400
Entest BioMedical's Subsidiary, Zander Therapeutics, Inc., Initiates Ex Vivo Studies on Modulating NR2F6 in Canines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.